Advertisement

Organisation › Details
Polyplus-transfection (Group)
Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery. *
![]() |
Start | 2001-01-01 splitoff |
Predecessor | University of Strasbourg | |
![]() |
Industry | transfection reagents |
![]() |
Person | Wilking, Karsten (Polyplus-transfection 2017– CEO before Life Technologies/Applied Bisystems/Invitrogen) |
Person 2 | Festoc, Gabriel (Polyplus-transfection 201609 CEO before CEO + Founder of GeneSystems) | |
![]() |
Region | Illkirch |
Country | France | |
Street | Boulevard Sébastien Brant Bioparc | |
City | 67400 Illkirch | |
Tel | +33-3-9040-6180 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | B: 11 to 50 (2015-01-13) |
* Document for �About Section�: Polyplus-transfection S.A.. (10/28/14). "Press Release: Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement for Use of PEI-based Transfection Technologies". Strasbourg. | ||
Record changed: 2020-11-05 |
Advertisement
![Picture [iito] Plain Stupid Simple 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-plain-stupid-simple.jpg)
More documents for Polyplus-transfection (Group)
- [1] Polyplus-transfection S.A.. (11/2/20). "Press Release: Polyplus-transfection Names Mario Philips as Chief Executive Officer". Illkirch....
- [2] Polyplus-transfection S.A.. (4/29/20). "Press Release: Growth Investment Is Set to accelerate Polyplus’ Expansion in Partnership with Warburg Pincus and ArchiMed". Illkirch....
- [3] Polyplus-transfection S.A.. (12/13/18). "Press Release: Polyplus-transfection further Expands Transfection Reagent Portfolio for Cell and Gene Therapy GMP production". Strasbourg....
- [4] Polyplus-transfection S.A.. (11/29/18). "Press Release: Polyplus-transfection Launches a Powerful Nanotechnology for DNA Transfection Composed of jetOptimus Reagent"....
- [5] Polyplus-transfection S.A.. (7/6/18). "Press Release: Polyplus-transfection Launches New Advanced System for Transient Protein Expression in CHO cells". Strasbourg....
- [6] Polyplus-transfection S.A.. (9/19/16). "Press Release: ArchiMed Acquires Biotech Specialist Polyplus-transfection"....
- [7] Lippold, Marcus. (1/30/15). "[LSE] Interview: An Exclusive Interview with Mark Bloomfield, CEO of Polyplus-transfection S.A., on the Policies of Larger Companies with Regard to IP of Smaller Firms (Part 3)"....
- [8] Lippold, Marcus. (1/13/15). "[LSE] Interview: An Exclusive Interview with Mark Bloomfield, CEO of Polyplus-transfection S.A., on the Policies of Larger Companies with Regard to IP of Smaller Firms"....
- [9] Lippold, Marcus. (1/13/15). "[LSE] Interview: An Exclusive Interview with Mark Bloomfield, CEO of Polyplus-transfection S.A., on the Policies of Larger Companies with Regard to IP of Smaller Firms (Part 2)"....
- [10] Polyplus-transfection S.A.. (10/28/14). "Press Release: Polyplus-transfection and Blue Sky BioServices Sign a Research and Commercial License Agreement for Use of PEI-based Transfection Technologies". Strasbourg....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]
Advertisement

» top